---
title: "Friday 4/24 Insider Buying Report: BFC, NTHI"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284041615.md"
description: "On April 24, insider buying activity was reported for Bank First (BFC) and NeOnc Technologies Holdings (NTHI). Director Todd A. Sprang bought 450 shares of BFC at $138.96 each, totaling $62,532, with BFC up 1.8% on the day. Meanwhile, President Amir F. Heshmatpour purchased $49,000 worth of NTHI, buying 10,000 shares at $4.90 each, although NTHI was down 2.3% on the day. Heshmatpour has previously invested $469,008 in NTHI over the past year."
datetime: "2026-04-24T17:55:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284041615.md)
  - [en](https://longbridge.com/en/news/284041615.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284041615.md)
---

# Friday 4/24 Insider Buying Report: BFC, NTHI

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.

At Bank First, a filing with the SEC revealed that on Wednesday, Director Todd A. Sprang purchased 450 shares of BFC, for a cost of $138.96 each, for a total investment of $62,532. Sprang was up about 4.0% on the purchase at the high point of today's trading session, with BFC trading as high as $144.50 at last check today. Bank First is trading up about 1.8% on the day Friday.

And on Thursday, President Amir F. Heshmatpour purchased $49,000 worth of NeOnc Technologies Holdings, purchasing 10,000 shares at a cost of $4.90 each. Before this latest buy, Heshmatpour purchased NTHI on 4 other occasions during the past year, for a total investment of $469,008 at an average of $5.86 per share. NeOnc Technologies Holdings is trading down about 2.3% on the day Friday.

**VIDEO: Friday 4/24 Insider Buying Report: BFC, NTHI**

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

### Related Stocks

- [NTHI.US](https://longbridge.com/en/quote/NTHI.US.md)
- [BFC.US](https://longbridge.com/en/quote/BFC.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [Vanguard Group Inc. Buys 10,052 Shares of Bank First National Corporation $BFC](https://longbridge.com/en/news/286550836.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)
- [Regenxbio's muscle disorder therapy meets main goal in late-stage study](https://longbridge.com/en/news/286406339.md)